Keytruda demonstrated a statistically significant and clinically meaningful improvement in event-free survival and major ...

Aspargo Labs uses a proprietary technology platform to reformulate oral medication to liquid doses. CEO and chairman Michael ...

The BrainSense adaptive deep brain stimulation system personalizes therapy by dynamically adjusting stimulation based on real ...

Vaxitek HVT+IBD+H5 integrates COBRA technology to address the ongoing viral evolution challenges of avian influenza, as well ...

Unconfirmed reports suggest that a popular flu vaccine educational campaign has come to an end.

Biopharmas and global agencies are now prioritizing initiatives and innovations to drive speed across product development ...

John Arena, interim president of global pharma services at Cencora, discusses how new technologies are shortening timelines.

According to ZERO Prostate Cancer, Novartis has committed $7.5 million to the initiative.

John Arena, interim president of global pharma services at Cencora, discusses the importance of engaging with partners as ...

Traditional approaches to HCP segmentation are no longer sufficient. The challenge now is to maintain personalization at ...

Pharm Exec’s 20th Annual Pipeline Report examines the emerging drug development trends and surging investments in five ...

The campaign is based on the results of a survey that reveals the experiences of patients and caregivers in their communities ...